Sam Brusco02.28.22
Masimo has earned U.S. Food and Drug Administration (FDA) clearance for SedLine brain function monitoring for patients aged 1-17, expanding its use to all patients one year and above in the U.S.
SedLine monitors brain activity bilaterally via processing electroencephalogram (EEG) signals from four-lead EEG sensors. Specially sized sensors were designed for pediatric patients’ smaller foreheads.
SedLine displays both EEG signals and a multitaper density spectral array (DSA) from both sides of the brain for a more complete picture.
“SedLine is an easy window into a child's electroencephalogram. It helps us to personalize sedoanalgesia, Dr. Cristina Verdú of Madrid’s Hospital Universitario La Paz told the press. “Now, we can choose the appropriate dose according to its effects, not just according to weight or age. But in addition to monitoring anesthetic depth, it allows us to detect warning signs such as asymmetries or seizures; it tells us what is happening to the child’s brain.”
“SedLine is achieving for brain function monitoring what Masimo SET did for pulse oximetry,” added Masimo CEO Joe Kiani. “We believe SedLine is the best and most advanced way to monitor depth of sedation, crucial to helping ensure patients with even the most challenging and the youngest brains are appropriately anesthetized. We are proud to be able to bring its benefits to children in the United States.”
SedLine monitors brain activity bilaterally via processing electroencephalogram (EEG) signals from four-lead EEG sensors. Specially sized sensors were designed for pediatric patients’ smaller foreheads.
SedLine displays both EEG signals and a multitaper density spectral array (DSA) from both sides of the brain for a more complete picture.
“SedLine is an easy window into a child's electroencephalogram. It helps us to personalize sedoanalgesia, Dr. Cristina Verdú of Madrid’s Hospital Universitario La Paz told the press. “Now, we can choose the appropriate dose according to its effects, not just according to weight or age. But in addition to monitoring anesthetic depth, it allows us to detect warning signs such as asymmetries or seizures; it tells us what is happening to the child’s brain.”
“SedLine is achieving for brain function monitoring what Masimo SET did for pulse oximetry,” added Masimo CEO Joe Kiani. “We believe SedLine is the best and most advanced way to monitor depth of sedation, crucial to helping ensure patients with even the most challenging and the youngest brains are appropriately anesthetized. We are proud to be able to bring its benefits to children in the United States.”